Friday, 30 August 2019

BioLargo Spotlight: BioLargo Engineering President Randall Moore Presents on the Company’s PFAS Treatment Technology at Sustain SoCal’s Water Solutions 4 Conference

On Thursday this week (August 29, 2019), BioLargo Engineering President Randall Moore was selected to join a panel of esteemed experts and thought leaders to discuss water contamination and solutions at Sustain SoCal’s Water Solutions 4 Conference at UC Irvine, where leaders in water remediation and management of emerging contaminants met to discuss potential solutions to a hot topic in water treatment – “PFAS” contaminants.

PFAS, or per-/poly-fluoroalkyl substances (PFAS), are a class of water contaminants of rising concern in the US and globally. PFAS have been linked to cancer, fertility problems, asthma, and more, and are present in a vast range of manufactured goods including food, common household products (e.g., cleaning products, cookware), and electronics. PFAS also pose widespread and serious water safety problems around the world, with governments and industry actively seeking new technologies and processes to eliminate PFAS from groundwater and drinking water.

In spring (2019), BioLargo Engineering was awarded an EPA SBIR Phase I grant to develop new solutions to treating PFAS contamination in water. According to BioLargo Engineering’s President Randall Moore, they’re already making great headway in developing a proprietary technology that has the potential to help solve the PFAS problem. Preliminary results in BioLargo Engineering’s work on its novel technology – the Aqueous Electrostatic Concentrator – have been promising, and the company expects to report more information soon. BioLargo Engineering was invited to take part in the Water Solutions 4 panel on PFAS contamination because of the company’s rising status as an innovator in PFAS contamination and management.

The conference had several noteworthy presenters including Congressman Harley Rouda, representative of California’s 48th district and Chairman of the Congressional Committee on the Environment and member of the Subcommittee on Water Resources and Environment. The conference’s title sponsors were the Metropolitan Water District of Southern California, the Moulton Niguel Water District, and BioLargo.

You can watch Randall Moore’s presentation about BioLargo Engineering’s PFAS treatment technology, delivered at Water Solutions 4, below. You can expect more news from BioLargo soon covering the company’s role in PFAS management and treatment.


Monday, 26 August 2019

An Interview with BioLargo CEO - August 26th 2019

An Interview with BioLargo CEO
"We Make Life Better"

DENVER, CO / ACCESSWIRE / August 26, 2019 / Tamarack Advisors recently sat down with Dennis Calvert, the CEO of BioLargo, Inc. (BLGO) to discuss their recent news and corporate developments. (Original Article Link)
Q: Over the last couple of months trading volume and share price for BioLargo have increased significantly. To what would you attribute this recent surge in interest in BLGO?
A: I think investors are starting to realize that BioLargo is well positioned for growth and financial success. We have achieved a number of important and high-value milestones. With basic due diligence, investors easily conclude that BioLargo has managed to conceive, develop, patent, prove, finance and is now actively commercializing a robust portfolio of sustainable and disruptive technologies and products focused on clean air, clean water, advanced wound care. In each of these areas, we have focused on technical innovations that we believe are the #1 technical solutions for the target problems. With the addition of BioLargo Engineering Science and Technologies, (BLEST) and the build out of our full services, design, construction, installation, service and maintenance teams at Odor No More, we can now offer customers both innovation and full-service solutions to some of the most difficult environmental and health related issues. Consider just a few of our most recent developments:

  • BioLargo Engineering (BLEST) landed contracts to serve seven United States Air Force bases focused on air quality
  • BLEST was awarded a “small business innovation research” grant by the EPA to tackle the removal of PFAS contamination from water (PFAS are fluorinated compounds considered one of the most pressing contamination issues of the past decade)
  • Begun selling products under our fourth “National Purchasing Agreement” with the largest waste handling companies in North America
  • Hired a former senior executive of a leading waste handling company to expand and grow sales of our odor control products
  • A third-party study confirmed CupriDyne Clean eliminates odors from marijuana and hemp growing and production operations
  • Successfully launched 2 pilots for the AOS clean water solution
  • Secured its 69th grant including funding to begin its third demonstration pilot in southern California to treat stormwater for its AOS
  • Secured new capital totaling more than $2.6 million
  • Refinanced or converted over $1.3 million in current liabilities
Q: The BLGO engineering division was recently awarded subcontracts to provide air quality engineering services to seven US Air Force bases. With a foot now in the door, what kind of potential is there for future contracts at US military bases?
A: We believe there is significant potential for future contracts with other Air Force bases (as well as other branches of the armed services), and we have multiple bids outstanding and more in process.
Q: Cannabis is a relatively new industry segment for BioLargo and its Odor and VOC products, tell us how you are making progress.
A: We secured our first distributor back in April of this year, with Mabre Air Systems, Inc. and their new operating unit Cannabusters, Inc. They are busy marketing the product and services across North America, including 2-3 trade show exhibits a month, and, the have reported recent success with customers in first commercial trials, its first system install, as well as a number of distributor relationships that are developing. We recently secured proof of claim for our product capabilities eliminating the odorous terpenes (gases) associated with cannabis and hemp production and processing (Link Here). We are working with Cannabusters to finely tune the product and services offering as we both find our way through this dynamic industry. With 15,000 licensing operators in California alone, we believe this is a very large and important opportunity. We have a great solution for this market!
Q: Regarding water treatment - BioLargo is currently conducting a live test of your AOS product on a poultry farm in Alberta, do you anticipate commercialization of the AOS soon?
A: The short answer is yes - this poultry process water demonstration pilot, which was recently featured in a short video, (video link), and the other pilot we have ongoing at a microbrewery in SoCal as well as the new project to treat captured stormwater in SoCal that just received a funding commitment , all combine to establish a cornerstone moment in the development cycle of the AOS. Demonstrating that your new technology works and has a strong economic value proposition in the field is a critical step for the development of any new, innovative technology, and that’s why this step is so important for our AOS. Once our demonstration pilots have concluded we’re moving on to commercial trials, manufacturing, then first sales. It’s hard to forecast an exact number of months until the technology is monetized, but we are getting very close, and for that reason we (and our stakeholders) are very excited for the AOS.
Q: Could you give us an update on your Clyra medical division and where you are in the FDA approval process?
A: Clyra is in the final stages of a current FDA application for pre-market clearance under 510(k). Our final task from the FDA was to demonstrate that the product does not interfere with normal wound healing processes. This was done through an animal study, and the work was recently and successfully completed. The testing laboratory has completed its formal report and we are readying to submit our final written response to the FDA. Once that is done, the FDA has a limited time to approve, or reject, our application. We are not aware of anything that would result in a rejection.
We are also excited about Clyra’s SkinDisc technology, which has been tested in over 250 patient cases and has successfully aided in the salvage of limbs that otherwise would have been amputated. The regenerative tissue therapy technique has been shown to assist in successful wound closure in time frames as short at 4 to 7 weeks with one or two applications and is patent pending.
Question: Any closing remarks?
A: We are better capitalized now that we have ever been, and we intend to use these resources to grow our company and increase our revenues as well as continue to strengthen our balance sheet. We have multiple winners in our portfolio and have never been more excited about our future.

Wednesday, 14 August 2019

BioLargo Second Quarter Report Highlights Continued Progress, New Revenue, Contracts, Pilot Projects and Strengthened Balance Sheet

Note: This press release will hit the national news wire tomorrow on 8/15/2019

Westminster, CA – August 15, 2019 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced the filing of its 10-Q quarterly report for the second quarter of 2019. Company management encourages its stockholders to review the quarterly report, which is linked HERE.

BioLargo President/CEO Dennis Calvert commented, “Our stockholders can feel very positive about our immediate and future prospects.  We have made tremendous improvements in our debt and cash position, and we have a number of business developments that help indicate how well positioned we are for continued revenue growth.” 

Highlights from the Quarterly Report:

·       Secured new capital totaling more than $2.6 million
·       Refinanced or converted over $1.3 million in current liabilities
·       Revenues for the six months were $790,000, an increase of 34% over the prior year
·       Sales of CupriDyne Clean based products increased 31% over the prior year
·       The company used $1,851,000 in cash for the six-month period ended June 30, 2019
·       Net loss for the six months decreased by 21% over last year, coming in at $4,736,000, compared to a loss of $6,029,000 for the prior year. Of this net loss, the amount attributable to non-cash charges to interest expense totaled $1,038,000
Highlights for Subsidiaries

Odor-No-More
  • Recent hire of 27-year waste handling industry veteran Mitch Noto to expand sales in the waste handling industry
  • Seeing increased support for CupriDyne Clean at the corporate level of our industry-leading waste handling companies (national purchasing agreements customers)
  • Confirmed CupriDyne Clean eliminates odors and volatile organic compounds (“VOCs”) emitted in cannabis and hemp growing and production, targeting this growing market (15,000 licensed growers in California alone)



BioLargo Engineering


  • Awarded multi-year contracts to provide air quality compliance and permitting at seven U.S. Air Force bases
  • Commenced EPA sponsored SBIR Phase 1 Grant to establish proof of viability for a system to assist in the removal of PFAS from water, with excellent prospect for follow-on contract to commercialize this system
  • Commenced client project to identify a solution for processing 1.1 million tons of magnesium-rich tailings in California coastal region
·
 Clyra Medical Technologies
  • Clyra in final stages of a current FDA application for pre-market clearance under 510 (k)
  • SkinDisc highlighted 250 pre-clinical successful cases for regenerative tissue and stem cell therapy technology
  • Negotiating license terms for complimentary FDA approved products 




     
BioLargo Water
  • Installed and operating a complete water treatment system in a demonstration pilot for treatment of poultry wastewater at an Alberta, Canada processing facility
  • Operating a component of a system in a demonstration pilot for treatment of microbrewery wastewater in Southern California
  • Received funding commitment for a demonstration pilot for treatment of storm wastewater in Southern California, representing our 69th grant and counting


President and CEO Dennis P. Calvert commented, “We are often complimented that it is rare to see a company with so many important and financially significant opportunities all breaking through at the same time. Both our engineering team at BLEST and our Odor-No-More team are heading into more predictable growth cycles.  The new contracts for BLEST to serve the USAF are significant, and we expect to win more soon. The addition of Mitch Noto to our team will help us organize to grow and serve the largest companies in the waste handling industry with the #1 product and services.  These dynamic business units are winning new business daily. We know that our substantial investments in Clyra Medical and BioLargo Water will yield substantial returns as they are poised for greatness.” 

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.



Tuesday, 6 August 2019

BioLargo Welcomes Waste Industry Veteran Mitch Noto to its Team


WESTMINSTER, Calif., August 6, 2019 (GLOBE NEWSWIRE) -- BioLargo, Inc. (BLGO), developer of sustainable products and technologies and a full-service environmental engineering company, today announced that waste handling industry veteran Mitch Noto had joined its team to support sales of its CupriDyne Clean odor-control product. With more than 28 years operations and environmental management experience at one of the largest waste handling companies in the United States, Mr. Noto brings invaluable experience and connections. He most recently spearheaded post-collection operations nationwide and trained and mentored more than 150 field leaders responsible for operational management. He is a recognized expert in waste handling operations. Combined with recent financing activities, BioLargo management believes it has the resources to leverage Mr. Noto’s talents to increase growth.  Mr. Noto will fill the role of Director of Corporate Development for BioLargo and serve as the Director of Business Development for BioLargo’s subsidiary Odor-No-More.
Odor-No-More, President Joseph Provenzano, “We are pleased that Mr. Noto has joined our team.  He brings his proven industry expertise and first-hand field operations knowledge that will help us continue to serve our customers with top performance and ‘best practices’ guidance. He will also help us expand market awareness for our odor elimination services and our industry-best odor control product CupriDyne® Clean.”

Mr. Noto commented, “After working with the Odor-No-More team for the past couple years, it was clear to me that this company would continue changing the way industrial odor control can and should be done. Additionally, their team and their products are best-of-class and I wanted to be associated with a company committed to a level of customer satisfaction that is unparalleled, that is obviously finding traction and is poised for substantial and rapid growth.”

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.


Monday, 5 August 2019

Dennis Calvert, CEO of BioLargo Inc. Joins the Stock Day Podcast to Discuss New Contracts and Federal Grants




Phoenix, Arizona--(Newsfile Corp. - August 5, 2019) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) ("the Company"), an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. BioLargo President and CEO Dennis P. Calvert joined Stock Day host Everett Jolly for an audio interview.
Jolly started by inquiring about BioLargo Engineering's recently announced subcontracts with the US Air Force, which the Company secured as part of a "teaming agreement" with Bhate Environmental Associates (disclosed in a press release here). Calvert explained that the government looks for qualified environmental engineering teams to provide monitoring, compliance, and maintenance to military bases. Applicants must meet strict qualifications in terms of finances, talent, and capability. Upon meeting these standards, the Company was chosen as a subcontractor to provide air quality services to several USAF locations. "It's a great development," stated Calvert.
Jolly then asked about the Company's AOS platform. Calvert explained that BioLargo offers a full-service solution by combining the engineering, infrastructure, installation, and service components of the water treatment process. "We have a special piece of technology in the AOS that allows us to take soluble organic contaminants and remove them from the water stream in a way that's never been done before," explained Calvert. He further explained that the Company just received financial support from (The National Research Council of Canada - Industrial Research Assistance Program, "NRC-IPRAP") to deploy the AOS in a demonstration pilot in Southern California to treat captured storm water.
To close the interview, Calvert shared that BioLargo's technologies would not have been possible without the patience and support of its investors. Calvert noted that the future of BioLargo will revolve around scalability and execution surrounding its technologies. "The future to us is really unlimited," he stated. "It's all about getting the right people, making sure the capital is in place, and then seeing these solutions go out to make the world a better place," he closed.
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
SOURCE:
Stock Day Media
602-441-3474

Friday, 2 August 2019

BioLargo 2019 Annual Meeting Presentation Video with Audio

On Wednesday, July 31st BioLargo held its Annual Meeting at its headquarters in Westminster, CA. At the meeting, leaders of each of the company's business units delivered a progress update and overview of future plans.

The Annual Meeting presentation that was delivered to shareholders is now available to view online right here at the blog, with audio!

View the full presentation here:





If you prefer to focus on a specific business unit of BioLargo, use the following links:

Skip to ONM's Presentation @ 16:20: https://youtu.be/-Pag-VAHIDo?t=980

Skip to BioLargo Engineering's Presentation @33:10: https://youtu.be/-Pag-VAHIDo?t=1990

Skip to Clyra's Presentation @ 47:10: https://youtu.be/-Pag-VAHIDo?t=2830 

Skip to BioLargo Water's Presentation @ 58:13: https://youtu.be/-Pag-VAHIDo?t=3493

(Proactive Investors Video) BioLargo awarded three contracts to provide air quality engineering services to US Air Force

Source: Proactive Investors


BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive Investors the the Westminster, California-based company's engineering subsidiary has been awarded a subcontract to provide air quality environmental engineering services to seven US Air Force bases in Texas, Arizona, Kansas, and Illinois.
Calvert says its a 'significant validation' to be selected because of the company's expertise, which translate to more customers, and revenue.